Practice
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Nextracker spinoff from Flex
We advised Nextracker on its spinoff
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
First Eagle Investments majority investment from Genstar Capital
We are advising First Eagle Investments on the transaction
PPL $2 billion at-the-market offering
We advised PPL on the offering
Meritage Group sale of interest in TowerPoint Infrastructure Partners
We are advising Meritage Group on the transaction
Williams $325 million acquisition of Rimrock gathering and processing system
We advised Williams on the transaction
TE Connectivity acquisition of Richards Manufacturing
We are advising TE Connectivity on the transaction
McKesson $850 million acquisition of controlling interest in PRISM Vision
We are advising McKesson on the transaction
Elliott Investment Management sale of Prosperity Life to JAB Holding Company
We are advising Elliott on the sale
Maze Therapeutics $140 million IPO
The shares are listed on Nasdaq
Kioxia Holdings ¥120.4 billion IPO
The shares are listed on the Tokyo Stock Exchange
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing